Labcorp’s $239 million offer was selected as the winning bid for the assets of genetic testing company Invitae, which filed for bankruptcy protection earlier this year. The acquisition deal, Labcorp's ...

Jeff Surges has 30 years of executive experience managing high-growth healthcare technology companies. As the CEO of RLDatix, he is responsible for overseeing and driving the strategic growth of ...

Gabby Everett, the site director for BioLabs Pegasus Park, offered a tour of the space and shared some examples of why early-stage life science companies should choose North Texas.

More than 33,000 Providence employees filed a class-action complaint against the health system in 2021, alleging that it had been withholding their wages by denying them breaks and rounding down their ...

The genetic medicines field is working toward therapies capable of doing their editing work inside the body by reaching many different types of tissue and cell types. Regeneron Pharmaceuticals and ...

As if news of record-high hospital bankruptcies and healthcare staff burnout wasn’t enough to shine a spotlight on the importance of revenue cycle management, just click around GoFundMe for ...

One quirk of the most common type of pediatric brain cancer is that as a child gets older, the tumors eventually stop growing. The reasons for this tumor senescence aren’t fully understood, but ...

As noted in the first article in this series, traditional value-based (VBC) care models are largely focused on economic incentives to healthcare providers and facilities. Many VBC organizations ...

Heart disease continues to be the leading cause of death and disability in the U.S. and worldwide. Atherosclerotic cardiovascular disease (ASCVD), which is caused by plaque buildup in arterial ...

New technologies are making it easier for companies to fix prices and discriminate against individual consumers, the Biden administration’s top consumer watchdog said Tuesday. Algorithms make it ...

Biopharma companies are responsible for some of the most transformative, life-changing technologies in medicine from gene therapy to immunotherapy. At the MedCity INVEST conference scheduled for ...